146 results about "Farnesol" patented technology

Provided is a composition comprising (a) at least one halogenated compound selected from the group consisting of C3-C5 hydrofluoroolefin, CF3I, and combinations thereof, and (b) an effective stabilizing amount of a sesquiterpene selected from the group consisting of farnesol, farnesene, and mixtures thereof.

A process for extracting the active components (farnesol, fatty aldehyde and edible fibres) from the momordica grosvenori dregs generated after extracting glycoside includes extracting seed oil, extracting farnesol by fraction, extracting fatty aldehyde from the water phase, and preparing edible fibres from the dregs by chemical or enzyme method. Its advantages are simple process and high output rate.

A flavor and fragrance composition possessing an antibacterial activity effective against periodontal disease-causing bacteria and / or a halitosis-inhibition action capable of controlling production of volatile sulfides, which is safe for the human body, and containing at least one or more substances selected from food fragrance materials such as hexylaldehyde, caryophyllene alcohol, cinnamicaldehyde, dihydroeugenol, farnesol, dihydrofarnesol, hinokitiol, isoeugenol, γ-undecalactone, d-limonene, o-methoxycinnamicaldehyde, β-pinene, γ-terpinene, terpinolene, orange oil, nutmeg oil, and grapefruit oil, and an oral care composition containing the same.

It is intended to provide a drug which is efficacious in treating and preventing diseases wherein ischemia or an inflammatory substance associated with ischemia participates in the onset or worsening thereof. Because of containing as the active ingredient a substance selected from among farnesol, a farnesol derivative, a tocopherol derivative, a tocotrienol derivative, pharmacologically acceptable salts thereof and solvates thereof, the above-described inhibitor of ischemic disorders can exert therapeutic and preventive effects on diseases wherein ischemia or an inflammatory substance associated with ischemia participates in the onset or worsening thereof (for example, brain infarction, brain edema, cardiac infarction, etc.) not only by the administration in the acute ischemic stage but also by the therapeutic administration in subacute and / or chronic stages after ischemia-reperfusion. It is also intended to provide a farnesol carboxylic acid ester derivative and a method of producing the same.

The invention discloses a method for extracting momordica grosvenori glycoside V and farnesol from grosvenor momordica fruits. Purified products of momordica grosvenori glycoside V and farnesol can be obtained by subjecting dry grosvenor momordica fruits to shelling, water extracting, filtering, resin adsorption, eluting by different-concentration ethanol, decoloring different eluent, crystallizing and recrystallizing. Reagents used in the method are all chemical reagents which are nontoxic, low-cost and massively produced, the mature normal reagent recovery technique can be used in the whole process, wastes discharged to the environment can be greatly reduced, operations are simple, production cost of the momordica grosvenori glycoside V and farnesol is greatly lowered, and the production process is simplified. Common raw materials and devices are used in the method, dependency on expensive raw materials and devices during industrial production is avoided, and accordingly production cost is greatly reduced.

The present invention provides a method for producing geranylgeraniol and analogous compounds thereof, which comprises culturing yeast cells (ascomycetes and deuteromycetes), bacterial cells, actinomycete cells or filamentous fungus cells, all of which are capable of producing geranylgeraniol and analogous compounds thereof, in a medium to produce and accumulate geranylgeraniol and analogous compounds thereof in the cells and / or in the extracellular environment; and then collecting these compounds. The present invention enables inexpensive mass production of geranylgeraniol and analogous compounds thereof by using microorganisms capable of producing geranylgeraniol, farnesol and / or nerolidol useful as biosynthetic intermediates of terpenes, carotenoids and / or steroids.

The invention discloses saccharomyces cerevisiae capable of auto-synthesizing terpenoid substances and applications thereof, belonging to the field of fermentation engineering. The saccharomyces cerevisiae capable of auto-synthesizing various terpenoid substances denovo is screened from fermented grains of white wine. The stain is preserved in the general microbiology centre in China on September 4, 2013, and the preservation number is CGMCC No.8130. The strain is subjected to liquid-state or solid-state fermented cultivation so as to generate ten kinds of terpenoid substances including linalool, alpha-terpineol, citronellol, myrcenol, nerolidol, alpha-dragosantol, farnesol, alpha-farnesene, beta-farnesene and bisabolene. The cerevisiae strain is added in the wine making process and can improve the flavor of white wine and increase the nutritive value of white wine.

The invention discloses a sweating suppression deodorant composition which comprises the following components in percentage by weight: 0.01-3% of cyperus rotundus root extract, 0.01-3% of farnesol, 0.01-3% of honeysuckle flower extract, 0.01-3% of mulberry leaf extract, 5-30% of antiperspirant, 0.1-3% of essential oil and the balance of auxiliaries. The sweating suppression deodorant composition disclosed by the invention can be prepared into multiple dosage forms; due to the interaction of multiple active components, the sweating suppression deodorant composition has the functions of suppressing sweat gland secretion, suppressing smelly bacteria, eliminating dampness with aromatics and protecting skin and diminishing inflammation; and the sweating suppression deodorant composition is rich in natural plant components and has the characteristics of little toxic and side effect, high effect taking speed, lasting effect and good clinical effect.

The invention discloses a method for improving Trametes versicolor laccase output. The method includes: at the mycelium growth stage of a Trametes versicolor laccase fermentation process, adding farnesol into a fermentation liquor, and further performing fermentation to produce laccase. By applying the method, the laccase output of the Trametes versicolor can be greatly improved. Also, the method is simple in operation, is easy for enlarged production, and is suitable for large-scale laccase fermentation, thereby reducing the laccase production cost, and meeting the requirements of large-scale application.

The present disclosure relates to a pharmaceutical composition, a health functional food composition, and a method for preventing or treating a brain disease or diabetes. The pharmaceutical composition, health functional food composition, and method includes at least one active ingredient that is chlorhexidine, thioguanosine, mebendazole, fenbendazole, colchicine, farnesol, trimethobenzamide hydrochloride, disulfuram, azathioprine, mebeverine hydrochloride, zaprinast, tosufloxacin hydrochloride, efavirenz, thiostrepton, probenecid, entacapone, harmine hydrochloride, flunisolide, thimerosal, hexestrol, sulfaquinoxaline sodium salt, monensin sodium salt, raloxifene hydrochloride, 2-chloropyrazine, or topotecan.

The invention relates to the field of plant disease prevention and control, in particular to application of farnesol as an antibacterial synergist in preventing and controlling plant grey mold. Particularly, the antibacterial synergist is applied to preventing and controlling the grey mold with a benzimidazole bactericide or triazole bactericide. The farnesol has the synergistic action to the bactericide, can improve the virulence of the bactericide by being used mixing with the bactericide, improves the sensibility of a drug-resistant strain to the bactericide and the prevention and control effect of the bactericide to the field drug-resistant grey mold, reduces the dosage of the bactericide and provides a new method to development and application of a novel preparation of the existing bactericide. Meanwhile, the farnesol is an extract of natural plants and is environmentally friendly. The invention provides a novel application of the drug, can be used for disease prevention and control in the agricultural field and provides a new way to grey mold field drug-resistant government.

The invention relates to a method for simultaneously detecting residual amounts of 13 phenolic alcohol sensitization aromatics in a toy. The method realizes simultaneous detection of 13 phenolic alcohol sensitization aromatics such as benzyl alcohol, linalool, 4-methoxyphenol, citronellol, geraniol, 4-ethoxyphenol, anise alcohol, p-tert-butylphenol, cinnamyl alcohol, eugenol, isoeugenol, amylcinnamyl alcohol and farnesol in a toy for the first time by the gas chromatography-ion trap tandem mass spectrometry technology, and fills the technical gap. The method can be used for detecting plush toys, paster toys and plastic toys (prepared from ABS, PVC and PS materials), and has a wide application range and strong applicability. The ion trap tandem mass spectrometry realizes qualification and quantification by two-stage mass spectrometry MS / MS and thus the method has good qualification and quantification effects on a toy sample having a complex matrix.

The invention discloses a spiro compound as well as a preparation method, a composition and application thereof. The spiro compound has a structure shown as a formula (I). The spiro compound disclosedby the invention can effectively treat Farnesol X receptor-mediated diseases and is more stable and long in half-life period.

The invention discloses anti-blue-light multi-effect repair eye cream and a preparation method thereof. The anti-blue-light multi-effect repair eye cream is prepared from the following ingredients: isohexadecane, isononyl isononanoate, crambe abyssinica seed oil, cetostearyl alcohol, phytosterol oleate, tocopherol acetate, propyl hydroxybenzoate, phenoxyethanol, triethanolamine, brown algae extract, theta-glucan, menthe piperita leaf extract, chrysanthellum indicum extract, purslane extract, radix sophorae extract, geranium pelargonium extract, glycerin, sodium benzoate, bisabolol, farnesol, butanediol, glycerin polyether-26, bio-saccharide gum-1, 0.2% of hydrolysis sclerotium gum, lecithin, allantoin and glucosylrutin. The natural extract is added for compound use, and the compounding ratio is limited, rich nourishing ingredients are contained, blue light can be resisted, moisture is replenished, the skin around the eyes is moisturized, the delicate skin is repaired, dryness and dehydration phenomena are smoothed, tightness, elasticity and moistening are achieved, fine lines are reduced, skin aging is delayed, and the eyes are beautiful.

The present invention relates to new types of farnesol alkoxylates, based on at least partially hydrogenated farnesol; processes for the preparation of these alkoxylates and the use thereof in washing, rinsing, cleaning or finishing compositions, cosmetic compositions, compositions for papermaking, fuel additives and solubilization auxiliaries in aqueous liquid systems.

The invention discloses a myliataylori sesquiterpene synthetase MTa and a gene sequence thereof. The gene is 1,383 bp in full length and encodes 460 amino acids, the molecular weight of enzyme proteinis 52.6 KDa, pESC-LEU yeast protein expression plasmids are adopted as carriers, and Saccharomyces cerevisiae WQ011 is adopted as a host, so that heterogenous expression of the myliataylori sesquiterpene synthetase MTa is achieved. A recombinant strain WQ011 / pESC-LEU-MTa can simultaneously produce two sesquiterpene alcohols, namely farnesol and nerolidol. The yields of nerolidol and farnesol in a50-mL shake flask are 1.03 mg / L and 2.00 mg / L respectively. Acquisition of the gene has profound significance on the research of sesquiterpene compounds of moss plants.

The invention provides an environment-friendly organic garden overlay composition which comprises the following components in parts by weight: 30-50 parts of garden wastes, 1-15 parts of honeycomb activated carbon, 5-20 parts of zeolite particles, 2-10 parts of an adhesive, 3-15 parts of modified chitosan, 10-30 parts of a matrix material and 10-30 parts of water. The modified chitosan is a chitosan-grafted imidazole heterocycle-containing biquaternary ammonium salt; the matrix material comprises the following raw preparative materials: PLGA, ferroferric oxide, polyvinyl alcohol, agarose, cellulase and farnesol; and the adhesive comprises the following raw preparative materials: ethylene-vinyl acetate copolymer, polyvinyl alcohol, a nonionic surfactant, an anionic surfactant, an anticorrosive and bactericidal agent and water.

The present invention relates to the new use of Shiliangcha extract in preparing medicine. Shiliangcha extract is mainly volatile oil prepared with the leaves of calycanthaceae plants, and with the main components including 1.8-cineole, broneol, linalool, benzyl alcohol, benzyl acetate, farnesol, terpineol, 1H-indole, etc. Pharmacological test shows that Shiliangcha extract has obvious effects of inhibiting diarrhea, stress ulcer and enteric hyperanacinesia, and lowering the gastric secretion and total acid displacement. It has high curative effect on abdominal mass and has also excellent curative effect on respiratory tract diseases.

The invention relates to a natural cleaning agent and a preparation method thereof. The natural cleaning agent is prepared from, by weight, 15%-20% of tea saponin, 5%-10% of lecithin, 0.02%-0.03% of tea polyphenol, 0.1%-0.2% of farnesol and the balance deionized water. The natural cleaning agent is mainly used for cleaning fruits and vegetables and especially can effectively remove residual pesticide on the surfaces of the fruits and the vegetables.

The present invention relates to one kind of caries-preventing toothpaste for children and its production process. The caries-preventing toothpaste has abrasive of very safe nanometer level soft silica; caries-preventing agent comprising propolis, farnesol and xylitol to replace fluoride; and tooth invigorating active components, including vitamin E, D-panthenol, active calcium, natural fruity perfume, etc. It has excellent effect of preventing caries, cleaning oral cavity and maintaining tooth health, high safety and no fluoride poisoning.

The invention discloses ivermectin and application of a derivative thereof, and relates to ivermectin. The ivermectin is a derivative of macrolide abamectin generated by streptomyces, and the ivermectin and the derivative thereof are used for preparing medicines for treating metabolism-related diseases such as mammalian hyperglycemia, insulin resistance, hypertriglyceridemia, hypercholesterolemia, diabetes and obesity, and can be applied to medicines for treating diseases such as farnesol receptor-mediated bile obstruction, gallstone, non-alcoholic fatty liver diseases, atherosclerosis, inflammation and cancer.

The invention discloses a tobacco feed liquid additive with anti-bacterial activity and application thereof. The tobacco feed liquid additive is prepared after glycerol, phenethyl alcohol, phenethyl acetate, vanillin, farnesol, phenylethyl propionate and rose flavone-S are uniformly and proportionally mixed. The rose flavone-S is a new flavonoid separated form waste residues which are obtained after rose essential oil is produced. The rose flavone-S is named as 2'-hydroxy-6-hydroxymethyl-7-methoxyflavone and has the structure shown in the description. When 5%-8% of the tobacco feed liquid additive is added into tobacco feed liquid, decomposition of the tobacco feed liquid is effectively inhibited, and the guarantee period of the tobacco feed liquid can be significantly prolonged. The throat comfort degree of cigarette smoking can be also improved, and the stimulation of smoking on the throat is reduced. The exquisite property and sweet sense of smoke are improved, and the smoke becomes smoother when passing through the throat and entering the nasal cavity. According to the tobacco feed liquid additive, the production technology is simple, sources of the raw materials are broad, the cost is low, additional values of rose processing are improved, waste resources are in comprehensive utilization, and the tobacco feed liquid additive has good application prospects.

The invention provides a composition for removing underarm odor, which mainly comprises the following materials by the weight part: 8 to 25 parts of murraya paniculata jack, 4 to 12 parts of thymifolious euphorbia herb, 3 to 12 parts of orthodon chinensis and 1 to 5 parts of farnesol, and the accessory materials which are acceptable in medicaments or household chemical products can be optionally added to be prepared into the medicaments or the household chemical products based on the conventional pharmaceutical technology, and the composition for removing underarm odor is a natural composition which combines fragrance, sweat gland secretion inhibition and bacterium sterilization and has no toxic or side effect. The composition has the advantages of convenient administration, rapid and durable effect, safety and no toxic or side effect, wherein the composition can be applied or sprayed in the underarm position for only one time, and remove the underarm odor immediately, and the effect can last 3 to 5 days; and the underarm odor can be fully removed by administration for a plurality of times.

The invention relates to a new technical method for increasing the enzyme activity of cellulase. In the fermentation and production process of the cellulase produced from fungal, farnesol is added to increase the enzyme activity of cellulase. By adding farnesol, the filter paper enzyme activity of the Trichoderma reesei cellulase-producing is increased by about 30% and the filter paper enzyme activity of Penicillium decumbens cellulase-producing is increased by about 46%. The method in the invention is simple and practical, the effect of increasing the enzyme activity of cellulase is obvious; and the method can be widely used and can be used in various cellulase-producing industries adopting fungal fermentation.

The invention belongs to the technical field of cosmetics, and particularly relates to lasting lip gloss and a preparation method thereof. The lip gloss is prepared from emollient, skin conditioning agents, a thickener, an antioxidant and a colorant. The colorant is composed of polymethylsilsesquioxane and CII 2490. The skin conditioning agent comprises bisabolol and farnesol. The lip gloss can keep stable and does not fade after being irradiated by outdoor sunshine, indoor fluorescent lamps and other light sources. The lip gloss is long in shelf life, unchanged in appearance and more stable in quality. The lip gloss can be scattered in a formula by being added into the formula and stirred or subjected to low-speed homogenization, and has heat resistance. Production efficiency is greatly improved, and the problems of losses, color difference and the like are reduced.

The invention discloses an application of farnesol in preventing and treating the smut disease of sugarcane and corn. According to the application of farnesol in preventing and treating smut disease,the life history of sugarcane smut can be affected. Farnesol has better inhibiting effect on the germination of teliospore, the proliferation and growth of basidiospore and the sexual cooperation. Theformation of the binuclear mycelium can be effectively blocked, the sugarcane can not be normally infected with sugarcane smut, and the occurrence of the smut disease of the sugarcane can be effectively inhibited; the proliferation and growth of corn smut can be affected and the occurrence of corn smut can be inhibited.

The invention relates to the use of substances that influence fungal dimorphism for reducing the adhesion of fungi to surfaces. The invention also relates to washing and / or cleaning agents, textile treating agents and cleaning agents for mouth, teeth or dentures and to the use of said substances in said agents. The inventive substances are selected from propolis extracts, plant extracts, cinnamic acid and the derivatives thereof, monoterpenes, sesquiterpenes and diterpenes and the derivatives thereof, especially fucoidine, anethol, geraniol, farnesol or farnesol acid.

A method of increasing PGC-1α gene expression, decreasing PARIS gene expression, or promoting farnesylation of PARIS in a mammalian cell, the method comprising administering an effective amount of farnesol, a pharmaceutically acceptable salt thereof, or a solvate thereof to the cell; and related methods and compositions.

The invention discloses new applicationfor fungicidal synergism of farnesol and methoxy acrylic fungicides to prevention and treatment of smut disease. The synergistic combination can be applied to prevention and treatment of sugarcane, corn and other crops caused by sporosorium and ustilago, has a high synergistic effect, and can significantly reduce the use of chemical pesticides, and the prevention and treatment effect is significantly better than that of a single agent.